- One Day Conference February 24, 2021
- 25 Minute presenting time slots from 9am to 2pm EST
- Presentation times and links distributed for all presenting companies
- Investors will be provided time after presentation to ask questions to management teams
- We welcome all institutional and retail investors
NEW YORK, NY / ACCESSWIRE / February 17, 2021 / "The Diamond Equity Research Emerging Growth Invitational offers a unique opportunity for investors to evaluate under the radar public companies and ask relevant questions directly to management in a streamlined convenient format. Our conferences are open to both institutional and retail investors, allowing all investors to obtain meaningful access to management teams," stated Hunter Diamond, CFA, the CEO of Diamond Equity Research.
Investors can register at https://www.diamondequityresearch.com/conferences/.
Virtual Agenda - Wednesday, February 24, 2021
|1:40-2:05||Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX)|
About Diamond Equity
Diamond Equity Research provides in-depth research and analysis on global micro capitalization and small capitalization equities. Diamond Equity Research distributes research to top investment platforms and investors globally, allowing companies to reach investors. Diamond Equity Research is a leading provider of institutional-quality research, including company-sponsored research. Diamond Equity Research holds quarterly investment conferences, allowing management and investors to meaningfully interact.
For additional questions or to connect with companies after the conference, contact the Diamond Equity Research conference team
Disclosures: Statements in these presentations may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be "forward-looking statements." Such statements are based on expectations, estimates, and projections at the time the statements are made and involve many risks and uncertainties such as competitive factors, technological development, market demand, and a particular company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues, which could cause actual results or events to differ materially from those presently anticipated. The purpose of this conference and recording of event is to extend visibility for these companies and is in no way a recommendation to buy, sell or hold the respective securities. The accuracy or completeness of any material provided is not guaranteed and, unless otherwise indicated, is provided by the companies themselves without Diamond Equity Research's oversight and/or endorsement. Diamond Equity Research may have positions in various presenting companies and may change or update its position without notice and without regard to any presented material by company. Conference participants are reminded to do their own due diligence when researching any companies attending the investment conference or prior to making any investment decisions. Investing in micro capitalization and small-capitalization securities is highly speculative with many risks, including a complete loss of one's principal. Various companies in this press release have paid to present at our emerging growth conference. Specific payment disclosures can be found on https://www.diamondequityresearch.com/disclosures/.
SOURCE: Diamond Equity Research LLC
View source version on accesswire.com: